Please login to the form below

Not currently logged in
Email:
Password:

compulsory licence

This page shows the latest compulsory licence news and features for those working in and with pharma, biotech and healthcare.

Amgen gets block on sales of Repatha rival in Germany

Amgen gets block on sales of Repatha rival in Germany

They also attempted to persuade the German authorities to issue a compulsory licence for Praluent, but that failed too.

Latest news

  • Buyers’ Club wants government support on Orkambi imports Buyers’ Club wants government support on Orkambi imports

    compulsory licensing) crown use licence, launch a large scale clinical trial and provide direct support for individuals using the buyers’ club. ... These would be aggressive moves against Vertex, with a ‘crown use’ licence representing an

  • Orkambi buyers’ club set up to gain access to cheaper versions Orkambi buyers’ club set up to gain access to cheaper versions

    The group wants the government to use its compulsory licensing laws, called Crown Use licence to bypass Vertex’s UK patents and procure these cheaper copies for use on the NHS. ... Earlier this year, health ministers more or less ruled out using the

  • UK patient activist group takes aim at Orkambi patent UK patient activist group takes aim at Orkambi patent

    Crown use is a little-known provision in UK law which allows the government to bypass patents and issue a compulsory licence on a medicine if there is deemed to be ... The push for compulsory licensing has been driven by a newly-formed patient activist

  • Bayer fails to overturn Nexavar compulsory licence in India Bayer fails to overturn Nexavar compulsory licence in India

    Natco Pharma allowed to sell cut-price version of cancer drug. Bayer's first attempt at overturning a compulsory license in India for its cancer drug Nexavar was knocked back yesterday ... Natco received the the compulsory licence in March 2012 on the

  • India's patents versus India's patients India's patents versus India's patients

    Alternatively, we might see more examples of compulsory licensing in India where a government allows a third party to produce a patented product without the consent of the patent owner. . ... In a landmark decision earlier this year, India granted its

More from news
Approximately 1 fully matching, plus 10 partially matching documents found.

Latest Intelligence

  • The Cystic Fibrosis Buyers’ Club The Cystic Fibrosis Buyers’ Club

    Just Treatment is also urging the UK government to override Vertex’s patent via compulsory licensing or Crown Use Licence.

  • Intellectual property threats in the BRIC markets Intellectual property threats in the BRIC markets

    Brazil, for example, used the threat of compulsory licensing to obtain discounts for various HIV drugs, before actually issuing a compulsory licence in 2007 for Stocrin. ... of the compulsory licence process for Herceptin, Sprycel and Ixempra,

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Dice Medical Communications

Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop...

Latest intelligence

InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping
Learn how a client engaged 18 rheumatologist advisors over 6 months to create a patient journey map for SLE....
Alone we can do so little, together we can do so much
Collaboration is at the heart of successful patient engagement and effective healthcare provision. But in such a complex, nuanced network, true collaborations are rare. So how can we, as an...
7 important considerations for creating an inclusive clinical trial website
You might have noticed that all of us here at COUCH Health are big advocates for taking action to improve diversity and inclusion in the world of clinical research. ‘Taking...

Infographics